ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AKLRD, Nordic Bioscience Collaborate to Study Novel Osteoarthritis Medicine
May 08, 2019AKL Research & Development (AKLRD) and Nordic Bioscience Clinical Development, announced a risk-share agreement to assess the efficacy of a novel, oral medicine, APPA, in a phase II trial of Osteoarthritis (OA). -
UK biotech gets grant for further trial of osteoarthritis drug
February 21, 2019UK biotech AKL Research and Development (AKLRD) has received a grant from a UK government-backed innovation body to develop its potentially “game changing” osteoarthritis drug.
Pharma Sources Insight January 2025
